$CTA-PA

EIDP, Inc.

CIK:0000030554|SEC Filings

Consolidated Statements of Operations - USD ($)
$ in Millions

3 Months Ended

6 Months Ended

Jun. 30, 2026

Jun. 30, 2025

Jun. 30, 2026

Jun. 30, 2025

Net Sales

$ 6,379

$ 6,456

$ 11,284

$ 10,873

Cost of Goods Sold

2,718

2,932

5,090

5,274

Research and Development Expense

388

375

729

710

Selling, General and Administrative Expenses

1,164

1,156

2,041

1,907

Amortization of Intangibles

194

161

354

323

Restructuring and asset related charges - net

^[1]

141

101

Business Separation Costs

131

Other income (expense) - net

(115)

103

(232)

118

Interest Expense

Income (loss) from continuing operations before income taxes

1,625

1,804

2,483

2,588

Provision for (benefit from) income taxes on continuing operations

408

422

541

539

Income (loss) from continuing operations after income taxes

1,217

1,382

1,942

2,049

(Income) loss from discontinued operations after income taxes

(52)

(66)

(54)

(77)

Net income (loss)

1,165

1,316

1,888

1,972

Net income (loss) attributable to noncontrolling interests

Net income (loss) attributable to Corteva

$ 1,161

$ 1,314

$ 1,881

$ 1,966

Basic earnings (loss) per share of common stock from continuing operations

$ 1.81

$ 2.02

$ 2.89

$ 2.99

Basic earnings (loss) per share of common stock from discontinued operations

(0.08)

(0.10)

(0.08)

(0.11)

Basic earnings (loss) per share of common stock

1.73

1.92

2.81

2.88

Diluted earnings (loss) per share of common stock from continuing operations

1.81

2.02

2.88

2.98

Diluted earnings (loss) per share of common stock from discontinued operations

(0.08)

(0.10)

(0.08)

(0.11)

Diluted earnings (loss) per share of common stock

$ 1.73

$ 1.92

$ 2.80

$ 2.87

EIDP

Net Sales

$ 6,379

$ 6,456

$ 11,284

$ 10,873

Cost of Goods Sold

2,718

2,932

5,090

5,274

Research and Development Expense

388

375

729

710

Selling, General and Administrative Expenses

1,164

1,156

2,041

1,907

Amortization of Intangibles

194

161

354

323

Restructuring and asset related charges - net

141

101

Business Separation Costs

131

Other income (expense) - net

(115)

103

(232)

118

Interest Expense

Income (loss) from continuing operations before income taxes

1,625

1,804

2,483

2,588

Provision for (benefit from) income taxes on continuing operations

408

422

541

539

Income (loss) from continuing operations after income taxes

1,217

1,382

1,942

2,049

(Income) loss from discontinued operations after income taxes

(52)

(66)

(54)

(77)

Net income (loss)

1,165

1,316

1,888

1,972

Net income (loss) attributable to noncontrolling interests

Net income (loss) attributable to Corteva

$ 1,164

$ 1,316

$ 1,886

$ 1,971

[1]	Includes restructuring plans and asset related charges. See Note 4 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information.

Consolidated Statements of Cash Flows - USD ($)
$ in Millions

3 Months Ended

6 Months Ended

12 Months Ended

Jun. 30, 2026

Mar. 31, 2026

Jun. 30, 2025

Mar. 31, 2025

Jun. 30, 2026

Jun. 30, 2025

Dec. 31, 2025

Net income (loss)

$ 1,165

$ 723

$ 1,316

$ 656

$ 1,888

$ 1,972

(Income) loss from discontinued operations after income taxes

Depreciation and Amortization

636

597

Provision for (benefit from) deferred income tax

232

(209)

Net Periodic Pension and OPEB (benefit) cost, net

(5)

Pension and OPEB Contributions

(1,140)

(84)

Net (gain) loss on sales of property, businesses, consolidated companies, and investments

(17)

Restructuring and asset related charges - net

^[1]

141

101

Other net loss

319

272

Accounts and notes receivable

(2,416)

(2,544)

Inventories

1,227

1,310

Accounts Payable

(487)

(356)

Deferred Revenue

(3,187)

(2,944)

Other Assets and Liabilities

(613)

667

Cash Provided by (Used for) Operating Activities, Continuing Operations

(3,345)

(1,139)

Cash Provided by (Used for) Operating Activities, Discontinued Operations

(12)

(23)

Cash Provided by (Used for) Operating Activities

(3,357)

(1,162)

Capital expenditures

(203)

(212)

Proceeds from sales of property, businesses, and consolidated companies - net of cash divested

Payments to Acquire Businesses, Net of Cash Acquired

(43)

Investments in and loans to nonconsolidated affiliates

(6)

Proceeds from Sale and Maturities of Investments

Proceeds from (payments for) settlement of net investment hedge

(56)

Other investing activities - net

(5)

(17)

Cash provided by (used for) investing activities

(247)

(198)

Net change in borrowings (less than 90 days)

2,398

Proceeds from debt

868

1,214

Payments on Debt

(989)

(335)

Repurchase of Common Stock

(500)

(520)

Proceeds from Exercise of Stock Options

Dividends paid to stockholders

(241)

(232)

Other financing activities, net

(37)

(38)

Cash provided by (used for) financing activities

1,530

187

Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash Equivalents

(32)

Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash

(2,106)

(1,105)

Cash, Cash Equivalents and Restricted Cash Equivalents at Beginning of Period

4,725

3,422

4,725

3,422

$ 3,422

Cash, Cash Equivalents and Restricted Cash Equivalents at End of Period

2,619

^[2]

2,317

^[2]

2,619

^[2]

2,317

^[2]

4,725

EIDP

Net income (loss)

1,165

723

1,316

656

1,888

1,972

(Income) loss from discontinued operations after income taxes

Depreciation and Amortization

636

597

Provision for (benefit from) deferred income tax

232

(209)

Net Periodic Pension and OPEB (benefit) cost, net

(5)

Pension and OPEB Contributions

(1,140)

(84)

Net (gain) loss on sales of property, businesses, consolidated companies, and investments

(17)

Restructuring and asset related charges - net

141

101

Other net loss

319

272

Accounts and notes receivable

(2,416)

(2,544)

Inventories

1,227

1,310

Accounts Payable

(487)

(356)

Deferred Revenue

(3,187)

(2,944)

Other Assets and Liabilities

(613)

667

Cash Provided by (Used for) Operating Activities, Continuing Operations

(3,345)

(1,139)

Cash Provided by (Used for) Operating Activities, Discontinued Operations

(12)

(23)

Cash Provided by (Used for) Operating Activities

(3,357)

(1,162)

Capital expenditures

(203)

(212)

Proceeds from sales of property, businesses, and consolidated companies - net of cash divested

Payments to Acquire Businesses, Net of Cash Acquired

(43)

Investments in and loans to nonconsolidated affiliates

(6)

Proceeds from Sale and Maturities of Investments

Proceeds from (payments for) settlement of net investment hedge

(56)

Other investing activities - net

(5)

(17)

Cash provided by (used for) investing activities

(247)

(198)

Net change in borrowings (less than 90 days)

2,398

Net payments from (advances to) Parent on in-house banking arrangement

(9)

Net payments from (advances to) Parent on in-house banking arrangement

129

Proceeds from debt

868

1,214

Payments on Debt

(989)

(335)

Proceeds from Exercise of Stock Options

Other financing activities, net

(28)

(31)

Cash provided by (used for) financing activities

1,530

187

Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash Equivalents

(32)

Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash

(2,106)

(1,105)

Cash, Cash Equivalents and Restricted Cash Equivalents at Beginning of Period

$ 4,725

$ 3,422

4,725

3,422

Cash, Cash Equivalents and Restricted Cash Equivalents at End of Period

2,619

2,317

2,619

2,317

$ 4,725

EIDP | Corteva [Member]

Dividends paid to stockholders

$ (370)

$ (375)

$ (741)

$ (888)

[1]	Includes restructuring plans and asset related charges. See Note 4 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information.
[2]	See Note 5 - Supplementary Information, to the interim Consolidated Financial Statements, for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025	Jun. 30, 2025
Cash and cash equivalents	$ 2,365	$ 4,521	$ 2,065
Marketable Securities	0	9	76
Accounts and notes receivable - net	8,696	6,371	8,674
Inventories	4,443	5,667	4,316
Other current assets	853	767	873
Total current assets	16,357	17,335	16,004
Investments in nonconsolidated affiliates	145	160	134
Property, Plant and Equipment	9,744	9,551	9,455
Less: Accumulated Depreciation	5,566	5,331	5,302
Net Property, Plant and Equipment	4,178	4,220	4,153
Goodwill	10,437	10,465	10,518
Other intangible assets	8,006	8,301	8,583
Deferred Income Taxes	335	320	449
Other assets	2,184	2,044	1,918
Total Assets	41,642	42,845	41,759
Short-term borrowings	3,193	894	1,942
Accounts payable	3,958	4,398	3,828
Income Taxes Payable	303	155	485
Deferred Revenue	383	3,579	358
Accrued and other current liabilities	2,952	3,099	2,903
Total current liabilities	10,789	12,125	9,516
Long-term Debt	1,682	1,686	1,687
Deferred income tax liabilities	512	251	258
Pension and other post employment benefits - noncurrent	1,300	2,434	2,229
Other noncurrent obligations	1,956	1,963	1,918
Total noncurrent liabilities	5,450	6,334	6,092
Common stock	7	7	7
Additional Paid in Capital	26,894	27,001	27,014
Retained earnings (accumulated deficit)	1,224	(67)	1,532
Accumulated Other Comprehensive Income (Loss)	(2,966)	(2,797)	(2,644)
Total stockholders' equity attributable to the company	25,159	24,144	25,909
Noncontrolling Interests	244	242	242
Total Equity	25,403	24,386	26,151
Liabilities and Equity	41,642	42,845	41,759
EIDP
Cash and cash equivalents	2,365	4,521	2,065
Marketable Securities	0	9	76
Accounts and notes receivable - net	8,696	6,371	8,674
Inventories	4,443	5,667	4,316
Other current assets	853	767	873
Total current assets	16,357	17,335	16,004
Investments in nonconsolidated affiliates	145	160	134
Property, Plant and Equipment	9,744	9,551	9,455
Less: Accumulated Depreciation	5,566	5,331	5,302
Net Property, Plant and Equipment	4,178	4,220	4,153
Goodwill	10,437	10,465	10,518
Other intangible assets	8,006	8,301	8,583
Deferred Income Taxes	335	320	449
Other assets	2,184	2,044	1,918
Total Assets	41,642	42,845	41,759
Short-term borrowings	3,193	894	1,942
Accounts payable	3,958	4,398	3,828
Income Taxes Payable	303	155	485
Deferred Revenue	383	3,579	358
Accrued and other current liabilities	2,958	3,223	2,899
Total current liabilities	10,795	12,249	9,512
Long-term Debt	1,682	1,686	1,687
Deferred income tax liabilities	512	251	258
Pension and other post employment benefits - noncurrent	1,300	2,434	2,229
Other noncurrent obligations	1,956	1,963	1,918
Total noncurrent liabilities	5,450	6,334	6,092
Common stock	0	0	0
Additional Paid in Capital	24,659	24,610	24,548
Retained earnings (accumulated deficit)	3,460	2,207	4,009
Accumulated Other Comprehensive Income (Loss)	(2,966)	(2,797)	(2,644)
Total stockholders' equity attributable to the company	25,392	24,259	26,152
Noncontrolling Interests	5	3	3
Total Equity	25,397	24,262	26,155
Liabilities and Equity	41,642	42,845	41,759
EIDP \| $4.50 Series Preferred Stock [Member]
Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at June 30, 2026, December 31, 2025, and June 30, 2025:	169	169	169
EIDP \| $3.50 Series Preferred Stock [Member]
Preferred stock, without par value – cumulative; 23,000,000 shares authorized; issued at June 30, 2026, December 31, 2025, and June 30, 2025:	$ 70	$ 70	$ 70